The Proteomics Centre has been providing an extensive range of cutting-edge proteomics services for more than 15 years, during which time clients from across Canada and in more than 15 countries have accessed its services on a fee-for-service or collaborative basis. The Proteomics Centre is now the best-equipped proteomics research facility in Canada.
With new funding from Genome Canada, the Proteomics Centre will expand to be a truly pan-Canadian enterprise. The Centre will establish a new node at Toronto’s Hospital for Sick Children, as well as a new site for clinical proteomics at Montreal’s Jewish General Hospital. This new Pan-Canadian Proteomics Centre will broaden in-house technological expertise, increase the range of technologies offered, increase capacity for core service provision and build a vital network of key collaborators. It will have a greater emphasis on translation of technologies into real-world applications and tighten linkages to clinical facilities. It has secured more than 60 projects, worth more than $7.8 million, for 2017-2022. It will develop and implement more than 1,400 new assays, extend or add value to 20 existing services, translate 150 assays into clinical settings, introduce 20 new crosslinkers, launch 11 new software tools and venture into new technology development areas, including proteogenomics.